BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17159717)

  • 21. Systemic sclerosis sine scleroderma: a case report of anterior uveitis.
    Borges T; Vilaça J; Ferreira S; Chora I; Silva S; Dias C
    Reumatismo; 2015 Jun; 67(1):21-5. PubMed ID: 26150271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and classification of systemic sclerosis.
    Hachulla E; Launay D
    Clin Rev Allergy Immunol; 2011 Apr; 40(2):78-83. PubMed ID: 20143182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Variability of the clinical picture and the classification of progressive systemic scleroderma].
    Giordano M; Ara M; Capelli L; Tirri G; Vatti M
    Z Rheumatol; 1976; 35(7-8):286-300. PubMed ID: 961080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais.
    Foocharoen C; Watcharenwong P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R
    Int J Rheum Dis; 2017 Oct; 20(10):1572-1581. PubMed ID: 28296274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early systemic sclerosis-opportunities for treatment.
    Sakkas LI; Simopoulou T; Katsiari C; Bogdanos D; Chikanza IC
    Clin Rheumatol; 2015 Aug; 34(8):1327-31. PubMed ID: 25711876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and Histopathological Features of Scleroderma-like Disorders: An Update.
    Foti R; De Pasquale R; Dal Bosco Y; Visalli E; Amato G; Gangemi P; Foti R; Ramondetta A
    Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database.
    Meier FM; Frommer KW; Dinser R; Walker UA; Czirjak L; Denton CP; Allanore Y; Distler O; Riemekasten G; Valentini G; Müller-Ladner U;
    Ann Rheum Dis; 2012 Aug; 71(8):1355-60. PubMed ID: 22615460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [How to recognize scleroderma].
    Francès C; Ayoub N; Barete S
    Rev Prat; 2002 Nov; 52(17):1884-90. PubMed ID: 12532864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The diagnosis and classification of scleroderma (systemic sclerosis).
    Barnett AJ; Miller M; Littlejohn GO
    Postgrad Med J; 1988 Feb; 64(748):121-5. PubMed ID: 3050937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Systemic sclerosis. A rare connective tissue disease with manifestations in many organs].
    Haugeberg G; Brodin C; Johnsen V
    Tidsskr Nor Laegeforen; 1995 Nov; 115(29):3619-21. PubMed ID: 8539716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort.
    Trapiella-Martínez L; Díaz-López JB; Caminal-Montero L; Tolosa-Vilella C; Guillén-Del Castillo A; Colunga-Argüelles D; Rubio-Rivas M; Iniesta-Arandia N; Castillo-Palma MJ; Sáez-Comet L; Egurbide-Arberas MV; Ortego-Centeno N; Freire M; Vargas-Hitos JA; Ríos-Blanco JJ; Todolí-Parra JA; Rodríguez-Carballeira M; Marín-Ballvé A; Chamorro-Fernández AJ; Pla-Salas X; Madroñero-Vuelta AB; Ruiz-Muñóz M; Fonollosa-Pla V; Simeón-Aznar CP;
    Autoimmun Rev; 2017 Aug; 16(8):796-802. PubMed ID: 28564618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity.
    Valentini G; Marcoccia A; Cuomo G; Vettori S; Iudici M; Bondanini F; Santoriello C; Ciani A; Cozzolino D; De Matteis GM; Cappabianca S; Vitelli F; Spanò A
    Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1520-7. PubMed ID: 24515450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-Scl-70 and anti-centromere autoantibodies. Biological markers of 2 forms of systemic scleroderma].
    Johanet C; Agostini MM; Vayssairat M; Abuaf N
    Presse Med; 1989 Feb; 18(5):207-11. PubMed ID: 2522207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical implications from capillaroscopic analysis in patients with Raynaud's phenomenon and systemic sclerosis.
    Herrick AL; Cutolo M
    Arthritis Rheum; 2010 Sep; 62(9):2595-604. PubMed ID: 20506306
    [No Abstract]   [Full Text] [Related]  

  • 35. [Digestive manifestations during systemic scleroderma].
    Gane S; Boicescu L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(6):515-20. PubMed ID: 2577013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical manifestations of systemic sclerosis.
    Steen VD
    Semin Cutan Med Surg; 1998 Mar; 17(1):48-54. PubMed ID: 9512107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [When thinking to scleroderma?].
    Cogan E
    Rev Med Brux; 2007 Sep; 28(4):285-9. PubMed ID: 17958022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome.
    Graf SW; Hakendorf P; Lester S; Patterson K; Walker JG; Smith MD; Ahern MJ; Roberts-Thomson PJ
    Int J Rheum Dis; 2012 Feb; 15(1):102-9. PubMed ID: 22324953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical distribution of anticentromere antibody in Japanese patients.
    Soma Y; Takehara K; Ishibashi Y
    Dermatologica; 1989; 178(1):16-9. PubMed ID: 2645177
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.